Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$1.67
-0.20 (-10.70%)
(As of 11/1/2024 ET)

SHPH vs. MEIP, KALA, NNVC, AKTX, PMN, COCP, BFRG, ATHA, FNCH, and GLMD

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include MEI Pharma (MEIP), KALA BIO (KALA), NanoViricides (NNVC), Akari Therapeutics (AKTX), ProMIS Neurosciences (PMN), Cocrystal Pharma (COCP), Bullfrog AI (BFRG), Athira Pharma (ATHA), Finch Therapeutics Group (FNCH), and Galmed Pharmaceuticals (GLMD). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs.

Shuttle Pharmaceuticals (NASDAQ:SHPH) and MEI Pharma (NASDAQ:MEIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings.

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 52.4% of MEI Pharma shares are held by institutional investors. 39.6% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 3.9% of MEI Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Shuttle Pharmaceuticals had 12 more articles in the media than MEI Pharma. MarketBeat recorded 13 mentions for Shuttle Pharmaceuticals and 1 mentions for MEI Pharma. Shuttle Pharmaceuticals' average media sentiment score of 0.05 beat MEI Pharma's score of -0.36 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shuttle Pharmaceuticals
0 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
MEI Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Shuttle Pharmaceuticals has a beta of -1.33, meaning that its share price is 233% less volatile than the S&P 500. Comparatively, MEI Pharma has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.

MEI Pharma received 397 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
Shuttle PharmaceuticalsN/AN/A
MEI PharmaOutperform Votes
397
61.84%
Underperform Votes
245
38.16%

MEI Pharma's return on equity of 51.00% beat Shuttle Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -217.60% -137.76%
MEI Pharma N/A 51.00%39.23%

MEI Pharma has higher revenue and earnings than Shuttle Pharmaceuticals. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than MEI Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$6.59M-$3.44-0.49
MEI Pharma$65.30M0.31$17.78M$2.671.15

MEI Pharma has a consensus target price of $7.00, indicating a potential upside of 128.01%. Given MEI Pharma's higher probable upside, analysts plainly believe MEI Pharma is more favorable than Shuttle Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shuttle Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
MEI Pharma
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

MEI Pharma beats Shuttle Pharmaceuticals on 10 of the 13 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$4.93M$7.02B$5.40B$8.53B
Dividend YieldN/A7.97%5.15%4.14%
P/E Ratio-0.499.53113.7615.14
Price / SalesN/A385.111,483.0493.53
Price / CashN/A47.3339.7134.04
Price / Book0.825.324.665.01
Net Income-$6.59M$153.56M$119.06M$225.46M
7 Day Performance33.60%0.12%0.79%0.37%
1 Month Performance40.34%15.23%5.65%3.57%
1 Year PerformanceN/A41.16%36.80%29.42%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
1.3613 of 5 stars
$1.67
-10.7%
N/AN/A$4.93MN/A-0.495News Coverage
MEIP
MEI Pharma
4.567 of 5 stars
$3.17
+2.6%
$7.00
+120.8%
-56.3%$21.11M$65.30M1.19100Analyst Forecast
News Coverage
Gap Down
High Trading Volume
KALA
KALA BIO
3.9148 of 5 stars
$7.19
flat
$16.50
+129.5%
+1.6%$20.25M$3.89M-0.5230
NNVC
NanoViricides
N/A$1.44
-5.3%
N/A+26.8%$20.02MN/A-2.0520Gap Up
AKTX
Akari Therapeutics
N/A$2.50
+4.2%
N/A-22.6%$19.81MN/A0.009Analyst Forecast
News Coverage
Gap Up
PMN
ProMIS Neurosciences
0.6803 of 5 stars
$1.03
-2.8%
N/A-33.1%$19.53M$10,000.00-1.726News Coverage
COCP
Cocrystal Pharma
2.7036 of 5 stars
$1.85
-0.5%
$7.00
+279.4%
+4.2%$19.20MN/A-1.0410
BFRG
Bullfrog AI
1.19 of 5 stars
$2.42
-0.8%
N/A-14.9%$19.00M$65,000.00-2.884Gap Up
ATHA
Athira Pharma
2.5581 of 5 stars
$0.48
flat
$13.83
+2,757.5%
-65.4%$18.74MN/A-0.1640Gap Up
FNCH
Finch Therapeutics Group
N/A$11.50
-2.1%
N/A+231.1%$18.47M$110,000.00-1.30190Gap Down
GLMD
Galmed Pharmaceuticals
1.7527 of 5 stars
$3.66
-6.2%
N/A-32.5%$18.47MN/A-0.2120

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners